Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid
Valens Establishes Operations in the Greater Toronto Area with the Acquisition of a Leading Beverage Company
Valens and BRNT Enter into Major White Label Deal with a Gross Revenue Potential to Valens of More Than $50 Million
Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update
Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products
Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company’s Cannabis Division
Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th
SAGA Metals Reports Assays from R-0030 to R-0035 with Intercepts Including 48.03% Fe2O3, 7.25% TiO2, 0.304% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
